CLINICS 2012;67(7):805-813 23. Gallo AP, Silva LB, Franco M, Burdmann EA, Bueno V. Tacrolimus in combination with FTY720 – an analysis of renal and blood parameters. Int Immunopharmacol. 2006;6(13-14):1919-24, http://dx.doi.org/ 10.1016/j.intimp.2006.07.012. 24. Lopes CT, Gallo AP, Palma PV, Cury PM, Bueno V. Skin allograft survival and analysis of renal parameters after FTY720 + Tacrolimus treatment in mice. Transplant Proc. 2008;40(3):856-60, http://dx.doi.org/ 10.1016/j.transproceed.2008.02.051. 25. Lopes CT, Rosin EC, Cordeiro JA, Bueno V. Cell phenotype evaluation at various sites after skin transplantation and FTY720 plus Sirolimus therapy. Transplant Proc. 2010;42(2):573-7, http://dx.doi.org/10.1016/ j.transproceed.2010.01.027. 26. Commodaro AG, Peron JP, Lopes CT, Arslanian C, Belfort R Jr., Rizzo LV, Bueno V. Evaluation of experimental autoimmune uveitis in mice treated with FTY720. Invest Ophtalmol Vis Sci. 2010;51(5):2568-74, http://dx.doi.org/10.1167/iovs.09-4769. 27. Chen H, Wang W, Xie H, Xu X, Wu J, Jiang Z, Zhang M, Zhou L, Zheng S. A pathogenic role of IL- 17 at the early stage of corneal allograft rejection. Transpl Immunol. 2009;21(3):155-61, http://dx.doi.org/ 10.1016/j.trim.2009.03.006. 28. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol. 2002;197(3):322-32, http://dx.doi.org/10.1002/path.1117. 29. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24(2):179-89, http://dx.doi.org/10.1016/j.immuni.2006.01.001. 30. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin- 23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003;278(3):1910-4, http:// dx.doi.org/10.1074/jbc.M207577200. 31. Mehling M, Lindberg R, Raul F, Kuhle J, Hess C, Kappos L, et al. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology. 2010;75(5)403-10, http://dx.doi.org/10.1212/ WNL.0b013e3181ebdd64. FTY720 treatment in skin allograft rejection Commodaro AG et al. 32. Wolf AM, Eller K, Zeiser R, D u¨rr C, Gerlach UV, Sixt M, Markut L, Gastl G, Rosenkranz AR, Wolf D. The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo. J Immunol. 2009;183(6):3751-60, http://dx.doi.org/10.4049/ jimmunol.0901011. 33. Zhou PJ, Wang H, Shi GH, Wang XH, Shen ZJ, Xu D. Immunomodulatory drug FTY720 induces regulatory CD4(+)CD25(+) T cells in vitro. Clin Exp Immunol. 2009;157(1):40-7, http://dx.doi.org/10.1111/j.1365-2249. 2009.03942.x. 34. Hester J, Mills N, Shankar S, Carvalho-Gaspar M, Friend P, Wood KJ. Th17 cells in Alemtuzumab-treated patients: the effect of long-term maintenance immunosuppressive therapy. Transplantation. 2011;91(7): 744-50. 35. Sewgobind VDKD, van der Laan LJW, Kho MML, Kraaijeveld R, Korevaar SS, Mol W, Weimar W, Baam CC. The calcineurin inhibitor tacrolimus allows the induction of functional CD4+CD25+ regulatory T cells by rabbit anti-thymocyte globulins. Clin Exp Immunol. 2010;161(2):364-77. 36. Battaglia M, Stabilini A, Draghici E, Gregori S, Mocchetti C, Bonifacio E. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes. 2006;55(1):40-9, http://dx.doi.org/10.2337/diabetes.55.01.06.db05-0613. 37. Yoshimoto T, Yoshimoto T, Yasuda K. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J Immunol. 2007;179(7):4415-23. 38. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol. 2006;7(9):937-45, http://dx.doi.org/ 10.1038/ni1376. 39. Li J, Lai X, Liao W, He Y, Liu Y, Gong J. The dynamic changes of Th17/ Treg cytokines in rat liver transplant rejection and tolerance. Int Immunopharmacol. 2011;11(8):962-7, http://dx.doi.org/10.1016/j. intimp.2011.02.010. 813